Clinical Trial Update: TMC114-TiDP29-C169: Bioavailability and Pharmacokinetics Trial Comparing Darunavir Pediatric Suspension Formulation to Current Darunavir Tablet [Phase 1]

View source ↗

Summary

Phase 1 bioavailability and pharmacokinetics study comparing the pediatric suspension formulation of darunavir to the current tablet was completed. The sponsor …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• PREZISTA (darunavir)

Snippet

Sponsor: Tibotec Pharmaceuticals, Ireland | Conditions: Pharmacokinetics | Phase 1 | Status: COMPLETED